The role of hepatic Surf4 in lipoprotein metabolism and the development of atherosclerosis in apoE−/− mice
Elevated plasma levels of low-density lipoprotein-C (LDL-C) increase the risk of atherosclerotic cardiovascular disease. Circulating LDL is derived from very low-density lipoprotein (VLDL) metabolism and cleared by LDL receptor (LDLR). We have previously demonstrated that cargo receptor Surfeit 4 (S...
Gespeichert in:
Veröffentlicht in: | Biochimica et biophysica acta. Molecular and cell biology of lipids 2022-10, Vol.1867 (10), p.159196-159196, Article 159196 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Elevated plasma levels of low-density lipoprotein-C (LDL-C) increase the risk of atherosclerotic cardiovascular disease. Circulating LDL is derived from very low-density lipoprotein (VLDL) metabolism and cleared by LDL receptor (LDLR). We have previously demonstrated that cargo receptor Surfeit 4 (Surf4) mediates VLDL secretion. Inhibition of hepatic Surf4 impairs VLDL secretion, significantly reduces plasma LDL-C levels, and markedly mitigates the development of atherosclerosis in LDLR knockout (Ldlr−/−) mice. Here, we investigated the role of Surf4 in lipoprotein metabolism and the development of atherosclerosis in another commonly used mouse model of atherosclerosis, apolipoprotein E knockout (apoE−/−) mice. Adeno-associated viral shRNA was used to silence Surf4 expression mainly in the liver of apoE−/− mice. In apoE−/− mice fed a regular chow diet, knockdown of Surf4 expression significantly reduced triglyceride secretion and plasma levels of non-HDL cholesterol and triglycerides without causing hepatic lipid accumulation or liver damage. When Surf4 was knocked down in apoE−/− mice fed the Western-type diet, we observed a significant reduction in plasma levels of non-HDL cholesterol, but not triglycerides. Knockdown of Surf4 did not increase hepatic cholesterol and triglyceride levels or cause liver damage, but significantly diminished atherosclerosis lesions. Therefore, our findings indicate the potential of hepatic Surf4 inhibition as a novel therapeutic strategy to reduce the risk of atherosclerotic cardiovascular disease.
•Surf4 mediates hepatic triglyceride secretion in apoE knockout mice.•Knockdown of Surf4 reduces plasma triglyceride and cholesterol levels in chow diet-fed apoE knockout mice.•Knockdown of Surf4 reduces the development of atherosclerosis in the Western-type diet-fed apoE knockout mice.•Surf4 silencing does not cause hepatic triglyceride accumulation or liver damage in apoE knockout mice fed regular chow or the Western-type diet. |
---|---|
ISSN: | 1388-1981 1879-2618 |
DOI: | 10.1016/j.bbalip.2022.159196 |